Clinical variables associated with PSA response to lutetium-177-PSMA ([177LU]-PSMA-617) radionuclide treatment in men with metastatic castration-resistant prostate cancer

Moran Gadot, Tima Davidson, Margalit Aharon, Eshetu G. Atenafu, Avraham Malki, Meital Levartovsky, Akram Saad, Liran Domachevsky, Raanan Berger*, Raya Leibowitz

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Clinical variables associated with PSA response to lutetium-177-PSMA ([177LU]-PSMA-617) radionuclide treatment in men with metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences